Li Li, MD
Dr. Li is an Assistant Professor for the Department of Genetics and Genomic Sciences and the Icahn Institute for Data Science and Genomic Technology. Dr. Li over 15 years experience in clinical informatics, precision medicine, and bioinformatics involving genetic and clinical risk factor identification, diagnostic assay development, and new therapeutic targets discovery. Her expertise is in translational research by integrating high-throughput genomics, genetics, various molecular measurements, and electronic medical records data with over 75 peer-reviewed publications including Science Translational Medicine, PNAS, Nature Methods, Nature Biotechnology, and JASN.
Her studies on identifying T2D sub populations through EMR has been recently featured by NIH director http://directorsblog.nih.gov/2015/11/10/big-data-reveals-possible-subtypes-of-type-2-diabetes/ and identifying risk factors through genetic architecture was highlighted by NIH director http://directorsblog.nih.gov/2014/05/06/mining-the-big-data-mountain/.
Her previous studies on developing novel diagnostic biomarker for tolerance, rejection post-transplantation cross-organ and steroid-avoidance treatment clinical studies have been awarded The Young Investigator Award in 2008, 2009, and 2010 in American Society of Transplantation, the distinguished research fellow in 2009, and The Transplantation Society (TTS) Astellas Young Investigators Award in 2010.
Bioinformatics, Computational Biology, Drug Design and Discovery, Fibrosis, Genetics, Genomics, Microarray, Tolerance, Transplantation